Manuscripts
Showing 1556 manuscripts.
Telephone support to improve antiretroviral medication adherence: a multisite, randomized controlled trial
Citation
Nancy Radcliffe Reynolds, Marcia A. Testa, Max Su, Margaret A. Chesney, Judith Neidig, Ian Frank, Scott R. Smith, Jeannette Ickovics, Gregory K. Robbins. Telephone support to improve antiretroviral medication adherence: a multisite, randomized controlled trial. Journal of Acquired Immune Deficiency Syndromes. 2008. 47: 62-8.Year
2008
Journal
Journal of Acquired Immune Deficiency Syndromes
Randomized study of dual versus single ritonavir-enhanced protease inhibitors for protease inhibitor-experienced patients with HIV
Citation
Ann C. Collier, Camlin Tierney, Gerald F. Downey, Susan H. Eshleman, Angela D.M. Kashuba, Karin L. Klingman, Emanuel N. Vergis, Gary E. Pakes, James F. Rooney, Alex R. Rinehart, John W. Mellors. Randomized study of dual versus single ritonavir-enhanced protease inhibitors for protease inhibitor-experienced patients with HIV. HIV Clinical Trials. 2008. 9: 91-102.Year
2008
Journal
HIV Clinical Trials
Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: results of ACTG A5186
Citation
John G. Gerber, Doug Kitch, Carl J. Fichtenbaum, Robert Zackin, Stephannie Charles, Evelyn Hogg, Edward P. Acosta, Elizabeth Connick, David Alain Wohl, Erna Milu Kojic, Constance A. Benson, Judith A. Aberg. Fish oil and fenofibrate for the treatment of hypertriglyceridemia in HIV-infected subjects on antiretroviral therapy: results of ACTG A5186. Journal of Acquired Immune Deficiency Syndromes. 2008. 47: 459-66.Year
2008
Journal
Journal of Acquired Immune Deficiency Syndromes
Association of efavirenz hypersusceptibility with virologic response in ACTG 368, a randomized trial of abacavir (ABC) in combination with efavirenz (EFV) and indinavir (IDV) in HIV-infected subjects with prior nucleoside analog experience
Citation
Lisa M. Demeter, Victor DeGruttola, Stephanie Lustgarten, Daniel Bettendorf, Margaret A. Fischl, Susan H. Eshleman, William Spreen, Bach-Yen Nguyen, Christine E. Koval, Joseph J. Eron, Scott M. Hammer, Kathleen E. Squires. Association of efavirenz hypersusceptibility with virologic response in ACTG 368, a randomized trial of abacavir (ABC) in combination with efavirenz (EFV) and indinavir (IDV) in HIV-infected subjects with prior nucleoside analog experience. HIV Clinical Trials. 2008. 9: 11-25.Year
2008
Journal
HIV Clinical Trials
Continuous improvement parameters in the immune system of HIV-infected children on prolonged antiretroviral therapy: results of PACTG 1021.
Citation
Adriana Weinberg, Ruth E. Dickover, Paula Britto, ChengCheng Hu, Julie A. Patterson, Howard Gutzman, William T. Shearer, Rebecca S. Gelman, Mobeen H. Rathore, Ross E. McKinney. Continuous improvement parameters in the immune system of HIV-infected children on prolonged antiretroviral therapy: results of PACTG 1021.. AIDS and Public Policy Journal. 2008. 22: 2267-77. PMID: 18981766Year
2008
Journal
AIDS and Public Policy Journal
Study
P1021
Lipid and glucose alterations in HIV-infected children beginning or changing antiretroviral therapy.
Citation
Caroline J. Chantry, Michael Hughes, Carmelita Alvero, Joseph S. Cervia, William A. Meyer, Janice Hodge, Peggy R. Borum, John ( Jack ) Moye. Lipid and glucose alterations in HIV-infected children beginning or changing antiretroviral therapy.. Pediatrics. 2008. 122: 129-38. PMID: 18519448Year
2008
Journal
Pediatrics
Study
P1010
Nevirapine concentrations in newborns receiving an extended prophylactic regimen.
Citation
Mark Mirochnick, Karin Alvarenga-Hyldgaard Nielsen, Jose Henrique Pilotto, Jorge Pinto, Eleanor Jimenez, Valdilea V. Santos, Teresa Parsons, Heather D. Watts, John ( Jack ) Moye, Lynne M. Mofenson, Margaret Camarca, Yvonne J. Bryson. Nevirapine concentrations in newborns receiving an extended prophylactic regimen.. Journal of Acquired Immune Deficiency Syndromes. 2008. 47: 334-7. PMID: 18398973Year
2008
Journal
Journal of Acquired Immune Deficiency Syndromes
Study
P1043/HPTN 040
Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children.
Citation
Myron Levin, Lin-Ye Song, Terence Fenton, Sharon Appelbaum Nachman, Julie A. Patterson, Robert Walker, George Kemble, Maria Allende, Micki Hultquist, Tingting Yi, Barbara Nowak, Adriana Weinberg. Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children.. Vaccine. 2008. 26: 4210-7. PMID: 18597900Year
2008
Journal
Vaccine
Study
P1057
Structured treatment interruptions (STIs) in HIV-1 infected pediatric populations increases interferon gamma production and reduces viremia
Citation
William Borkowsky, Ram Yogev, Petronella Muresan, Lisa M. Frenkel, Terence Fenton, Edmund Capparelli, John ( Jack ) Moye, Paul Harding, Nina Ellis, Barbara E. Heckman. Structured treatment interruptions (STIs) in HIV-1 infected pediatric populations increases interferon gamma production and reduces viremia. Vaccine. 2008. 26: 3086-9.Year
2008
Journal
Vaccine
Study
P1015
Coreceptor Tropism in Human Immunodeficiency Virus Type 1 Subtype D: High Prevalence of CXCR4 Tropism and Heterogeneous Composition of Viral Populations
Citation
Coreceptor Tropism in Human Immunodeficiency Virus Type 1 Subtype D: High Prevalence of CXCR4 Tropism and Heterogeneous Composition of Viral Populations. Journal of Virology. 2008. 81: 7885-7893. PMID: 17507467Year
2008
Journal
Journal of Virology